Cannabinoids and reduced risk of hepatic steatosis in HIV-HCV co-infection: paving the way for future clinical research - Archive ouverte HAL Access content directly
Journal Articles EXPERT REVIEW OF ANTI-INFECTIVE THERAPY Year : 2018

Cannabinoids and reduced risk of hepatic steatosis in HIV-HCV co-infection: paving the way for future clinical research

(1) , , , , (1)
1

Dates and versions

hal-02146867 , version 1 (04-06-2019)

Identifiers

Cite

Fabienne Marcellin, Helene Fontaine, Lawrence Serfaty, Philippe Sogni, Patrizia M. Carrieri. Cannabinoids and reduced risk of hepatic steatosis in HIV-HCV co-infection: paving the way for future clinical research. EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2018, 16 (5), pp.377-380. ⟨10.1080/14787210.2018.1473764⟩. ⟨hal-02146867⟩
17 View
0 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More